A citation-based method for searching scientific literature

Michael Karsy, Jian Guan, Adam Cohen, Howard Colman, Randy L Jensen. Neurosurg Clin N Am 2016
Times Cited: 26







List of co-cited articles
204 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Thomas J Kaley, Patrick Wen, David Schiff, Keith Ligon, Sam Haidar, Sasan Karimi, Andrew B Lassman, Craig P Nolan, Lisa M DeAngelis, Igor Gavrilovic,[...]. Neuro Oncol 2015
143
34

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Felix Sahm, Daniel Schrimpf, Damian Stichel, David T W Jones, Thomas Hielscher, Sebastian Schefzyk, Konstantin Okonechnikov, Christian Koelsche, David E Reuss, David Capper,[...]. Lancet Oncol 2017
341
34

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
34

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Victoria E Clark, E Zeynep Erson-Omay, Akdes Serin, Jun Yin, Justin Cotney, Koray Ozduman, Timuçin Avşar, Jie Li, Phillip B Murray, Octavian Henegariu,[...]. Science 2013
496
30

EANO guidelines for the diagnosis and treatment of meningiomas.
Roland Goldbrunner, Giuseppe Minniti, Matthias Preusser, Michael D Jenkinson, Kita Sallabanda, Emmanuel Houdart, Andreas von Deimling, Pantelis Stavrinou, Florence Lefranc, Morten Lund-Johansen,[...]. Lancet Oncol 2016
390
30

Epidemiology and etiology of meningioma.
Joseph Wiemels, Margaret Wrensch, Elizabeth B Claus. J Neurooncol 2010
598
26

Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.
Marc C Chamberlain, Michael J Glantz, Camilo E Fadul. Neurology 2007
121
26

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.
Thomas Kaley, Igor Barani, Marc Chamberlain, Michael McDermott, Katherine Panageas, Jeffrey Raizer, Leland Rogers, David Schiff, Michael Vogelbaum, Damien Weber,[...]. Neuro Oncol 2014
126
23


Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
Leland Rogers, Igor Barani, Marc Chamberlain, Thomas J Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C Weber, Patrick Y Wen, Michael A Vogelbaum. J Neurosurg 2015
311
23


An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas.
Sam Q Sun, Ammar H Hawasli, Jiayi Huang, Michael R Chicoine, Albert H Kim. Neurosurg Focus 2015
82
19


Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.
Adriana Olar, Khalida M Wani, Charmaine D Wilson, Gelareh Zadeh, Franco DeMonte, David T W Jones, Stefan M Pfister, Erik P Sulman, Kenneth D Aldape. Acta Neuropathol 2017
75
19

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
Priscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, Robert T Jones, Aaron McKenna, Gad Getz, Keith L Ligon, Emanuele Palescandolo, Paul Van Hummelen, Matthew D Ducar,[...]. Nat Genet 2013
383
19

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Andrew D Norden, Keith L Ligon, Samantha N Hammond, Alona Muzikansky, David A Reardon, Thomas J Kaley, Tracy T Batchelor, Scott R Plotkin, Jeffrey J Raizer, Eric T Wong,[...]. Neurology 2015
51
19

An overview of meningiomas.
Robin A Buerki, Craig M Horbinski, Timothy Kruser, Peleg M Horowitz, Charles David James, Rimas V Lukas. Future Oncol 2018
126
19

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
Quinn T Ostrom, Gino Cioffi, Haley Gittleman, Nirav Patil, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2019
939
19

Molecular genetics of meningiomas.
Brian T Ragel, Randy L Jensen. Neurosurg Focus 2005
60
15

Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium-size meningiomas.
Bruce E Pollock, Scott L Stafford, Andrew Utter, Caterina Giannini, Shawn A Schreiner. Int J Radiat Oncol Biol Phys 2003
195
15

CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.
Quinn T Ostrom, Haley Gittleman, Peter Liao, Toni Vecchione-Koval, Yingli Wolinsky, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2017
852
15

Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
Manish K Aghi, Bob S Carter, Garth R Cosgrove, Robert G Ojemann, Sepideh Amin-Hanjani, Robert L Martuza, William T Curry, Fred G Barker. Neurosurgery 2009
308
15

WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant?
Mathew J Gallagher, Michael D Jenkinson, Andrew R Brodbelt, Samantha J Mills, Emmanuel Chavredakis. Clin Neurol Neurosurg 2016
56
15

The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.
Katherine Striedinger, Scott R VandenBerg, Gilson S Baia, Michael W McDermott, David H Gutmann, Anita Lal. Neoplasia 2008
102
15

Radiosurgery as definitive management of intracranial meningiomas.
Douglas Kondziolka, David Mathieu, L Dade Lunsford, Juan J Martin, Ricky Madhok, Ajay Niranjan, John C Flickinger. Neurosurgery 2008
264
15

Review of controversies in management of non-benign meningioma.
Iddo Paldor, Mohammed Awad, Yuval Z Sufaro, Andrew H Kaye, Yigal Shoshan. J Clin Neurosci 2016
25
16

Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.
T W Dziuk, S Woo, E B Butler, J Thornby, R Grossman, W S Dennis, H Lu, L S Carpenter, J K Chiu. J Neurooncol 1998
192
15

Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
Salah Hammouche, Simon Clark, Alex Hie Lin Wong, Paul Eldridge, Jibril Osman Farah. Acta Neurochir (Wien) 2014
94
15

Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.
Victoria E Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W Youngblood, Tong Ihn Lee, Jacob F Baranoski, A Gulhan Ercan-Sencicek, Brian J Abraham, Abraham S Weintraub, Denes Hnisz,[...]. Nat Genet 2016
176
15

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
Malak Abedalthagafi, Wenya Linda Bi, Ayal A Aizer, Parker H Merrill, Ryan Brewster, Pankaj K Agarwalla, Marc L Listewnik, Dora Dias-Santagata, Aaron R Thorner, Paul Van Hummelen,[...]. Neuro Oncol 2016
154
15

TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Felix Sahm, Daniel Schrimpf, Adriana Olar, Christian Koelsche, David Reuss, Juliane Bissel, Annekathrin Kratz, David Capper, Sebastian Schefzyk, Thomas Hielscher,[...]. J Natl Cancer Inst 2015
194
15

Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
Svetlana Pravdenkova, Ossama Al-Mefty, Jeffrey Sawyer, Muhammad Husain. J Neurosurg 2006
97
15

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, Andrew D Norden, Timothy F Cloughesy, Lauren E Abrey, Howard A Fine, Susan M Chang, H Ian Robins, Karen Fink,[...]. Neuro Oncol 2009
90
15

Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
David E Reuss, Rosario M Piro, David T W Jones, Matthias Simon, Ralf Ketter, Marcel Kool, Albert Becker, Felix Sahm, Stefan Pusch, Jochen Meyer,[...]. Acta Neuropathol 2013
149
15

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
Leland Rogers, Peixin Zhang, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, James Galvin, David Brachman, Joseph M Jenrette,[...]. J Neurosurg 2018
117
15

Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.
Thomas Graillon, Marc Sanson, Chantal Campello, Ahmed Idbaih, Matthieu Peyre, Hadrien Peyrière, Noémie Basset, Didier Autran, Catherine Roche, Michel Kalamarides,[...]. Clin Cancer Res 2020
42
15

Relationship between tumor location, size, and WHO grade in meningioma.
Stephen T Magill, Jacob S Young, Ricky Chae, Manish K Aghi, Philip V Theodosopoulos, Michael W McDermott. Neurosurg Focus 2018
50
15

Towards Molecular Classification of Meningioma: Evolving Treatment and Diagnostic Paradigms.
Dustin T Proctor, Sudheesh Ramachandran, Sanju Lama, Garnette R Sutherland. World Neurosurg 2018
29
15

Advances in multidisciplinary therapy for meningiomas.
Priscilla K Brastianos, Evanthia Galanis, Nicholas Butowski, Jason W Chan, Ian F Dunn, Roland Goldbrunner, Christel Herold-Mende, Franziska M Ippen, Christian Mawrin, Michael W McDermott,[...]. Neuro Oncol 2019
47
15

Radiation Treatment for WHO Grade II and III Meningiomas.
Brian P Walcott, Brian V Nahed, Priscilla K Brastianos, Jay S Loeffler. Front Oncol 2013
52
11

The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial.
Michael D Jenkinson, Mohsen Javadpour, Brian J Haylock, Bridget Young, Helen Gillard, Jacqui Vinten, Helen Bulbeck, Kumar Das, Michael Farrell, Seamus Looby,[...]. Trials 2015
110
11

The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.
Konstantinos Gousias, Johannes Schramm, Matthias Simon. J Neurosurg 2016
99
11

The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.
A Perry, S L Stafford, B W Scheithauer, V J Suman, C M Lohse. Cancer 1998
188
11

Germline and somatic mutations in meningiomas.
Miriam J Smith. Cancer Genet 2015
44
11

Meningioma: analysis of recurrence and progression following neurosurgical resection.
R O Mirimanoff, D E Dosoretz, R M Linggood, R G Ojemann, R L Martuza. J Neurosurg 1985
760
11

Genomic landscape of intracranial meningiomas.
Wenya Linda Bi, Malak Abedalthagafi, Peleg Horowitz, Pankaj K Agarwalla, Yu Mei, Ayal A Aizer, Ryan Brewster, Gavin P Dunn, Ossama Al-Mefty, Brian M Alexander,[...]. J Neurosurg 2016
61
11

MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma.
Maomao Wang, Xiaodong Deng, Qi Ying, Tingyan Jin, Ming Li, Chong Liang. Biochem Biophys Res Commun 2015
26
11

Genomic profile of human meningioma cell lines.
Yu Mei, Wenya Linda Bi, Noah F Greenwald, Nathalie Y Agar, Rameen Beroukhim, Gavin P Dunn, Ian F Dunn. PLoS One 2017
34
11

Epigenetics: a new tool for meningioma management?
Marc Sanson, Michel Kalamarides. Lancet Oncol 2017
8
37


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.